| Field | Specification |
|---|---|
| Target | |
| Alternative names | Matrix metalloproteinase-9;MMP-9;3.4.24.35;92 kDa gelatinase;92 kDa type IV collagenase;Gelatinase B;GELB;Mmp9;Clg4b; |
| UniProt # | |
| Host | |
| Clonality | |
| Isotype | |
| Reactivity | |
| Applications | |
| Immunogen | A synthetic peptide corresponding to a sequence at the C-terminus of mouse MMP-9, different from the related human sequence by thirteen amino acids, and from the related rat sequence by eight amino acids. |
| Molecular weight | |
| Purification | |
| Reconstitution | |
| Cellular localization | |
| Concentration | |
| Form | Lyophilized |
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
This rabbit polyclonal antibody detects matrix metalloproteinase-9 (gene Mmp9) in mouse and rat samples and is validated for IHC and Western blot. The predicted molecular weight is 80.5 kDa, and the supplier reports an observed band at about 78 kDa.
MMP-9 (gelatinase B) is a secreted matrix metalloproteinase that degrades type IV and V collagens, gelatin and other matrix proteins. It supports leukocyte migration, tissue remodeling and osteoclast bone resorption, and it is widely measured in studies of inflammation, vascular disease, and tumor invasion.
| Target | Matrix metalloproteinase-9 (gene Mmp9; UniProt P41245, mouse) |
|---|---|
| Host / Clonality / Isotype | Rabbit / Polyclonal / Rabbit IgG |
| Reactivity | Mouse, Rat |
| Form | Lyophilized |
| Formulation | Per vial: 0.9 mg NaCl; 0.2 mg Na2HPO4; 0.05 mg NaN3; plus stabilizers |
| Calculated MW | 80.5 kDa |
| Observed MW | 78 kDa |
| Storage | As supplied: −20 °C for up to 12 months from receipt. After reconstitution: 4 °C for up to 1 month, or aliquot and keep at −20 °C for up to 6 months. Avoid repeated freeze–thaw cycles. |
Validated Applications
| IHC (paraffin sections) | 0.5–1 µg/mL (Mouse, Rat) |
|---|---|
| Western blot | 0.1–0.5 µg/mL (Mouse, Rat) |
Samples with a confirmed band (WB): NRK cells, ANA-1 cells, HEPA cells.
Recommended loading (WB): 20–40 µg of total protein per lane.
Conditions in the example images (WB): 5–20% gradient SDS-PAGE under reducing conditions, 40 µg lysate per lane, transfer to nitrocellulose membrane, blocking in 5% non-fat milk, primary antibody at 0.5 µg/mL overnight at 4 °C, HRP-conjugated secondary antibody at 1:5000, ECL detection.
Samples with confirmed staining (IHC): mouse kidney tissue, rat liver tissue.
Recommended antigen retrieval: heat-mediated, in TE buffer (pH 9.0); citrate buffer (pH 6.0) can be used instead.
Conditions in the example images (IHC): heat-mediated antigen retrieval in EDTA buffer (pH 8.0).
Immunogen
Synthetic peptide from the C-terminal region of mouse MMP-9. It differs from the human sequence at thirteen residues and from the rat sequence at eight residues.
Reactivity Notes
The supplier lists reactivity with mouse and rat. The samples tested by the supplier (listed above) are a practical starting point for positive controls.
Safety
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
Xinbo Wei et al. (2025) Neutrophil Membrane-Engineered Extracellular Vesicles from Perivascular Adipose Tissue-Derived Stromal Cells for Atherosclerotic Lesion Resolution and Enhanced Vascular Graft Remodeling. Advanced Functional Materials. 10.1002/adfm.202503873
Zhongwang Yu et al. (2022) Microglia Regulate Blood–Brain Barrier Integrity via MiR-126a-5p/MMP9 Axis during Inflammatory Demyelination. Advanced Science. 10.1002/advs.202105442
Chenxi Wang et al. (2026) TRAP5 Inhibition Targeting Scar-Associated Macrophages Ameliorates Acute Kidney Injury to Chronic Kidney Disease Transition. Advanced Science. 10.1002/advs.202519855
Xiaoyan Bao et al. (2025) Targeted Neuroimmune Modulation via FGF21-Loaded Dual-Layer Electrospun Nanofibrous Scaffold to Suppress Secondary Injury After Severe Traumatic Brain Injury. Advanced Healthcare Materials. 10.1002/adhm.202500905
Zhen Huang et al. (2016) Targeted delivery of let-7b to reprogramme tumor-associated macrophages and tumor infiltrating dendritic cells for tumor rejection. Biomaterials. 10.1016/j.biomaterials.2016.03.009
Xiudan Zhan et al. (2014) Targeted depletion of tumour-associated macrophages by an alendronate–glucomannan conjugate for cancer immunotherapy. Biomaterials. 10.1016/j.biomaterials.2014.09.007
Jia-ning Gong et al. (2026) Platycodin D alleviates idiopathic pulmonary fibrosis by targeting PPP2R1A and regulating the PP2A-mediated PI3K/Akt pathway to inhibit fibroblast transdifferentiation. Phytomedicine. 10.1016/j.phymed.2026.158000
Dali Ding et al. (2023) Timosaponin BII inhibits TGF-β mediated epithelial-mesenchymal transition through Smad-dependent pathway during pulmonary fibrosis. Phytotherapy Research. 10.1002/ptr.7774
Shaoru Zhang et al. (2022) Chronic exposure to microcystin-leucine-arginine induces epithelial hyperplasia and inflammation in the mouse bladder. Ecotoxicology and Environmental Safety. 10.1016/j.ecoenv.2022.114033
Ping-Fang Hu et al. (2009) Adenovirus-mediated transfer of siRNA against PAI-1 mRNA ameliorates hepatic fibrosis in rats. Journal of Hepatology. 10.1016/j.jhep.2009.02.025
